検索結果

Milestones in Our History | About Senju | SENJU Pharmaceutical

1947 Apri Hiroshi Tsuzuki (CEO) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 Feb...

論文投稿実績 | 研究開発活動 | 千寿製薬株式会社

愛媛大学医学部眼科学教室　2)千寿製薬株式会社　3)日野病院 あたらしい眼科42(12)：1566～1576 Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuk...

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

mer products we manufacture have been carefully developed to satisfy current needs-they can be used with the assurance that every product meets the same high standards for quality and safety that appl...

し，適正使用に関する理解を促すため。12 重要な不足情報 なし 引用文献 Touyz RM, Herrmann SMS, Herrmann J (2018) Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events. J Am Soc Hyperte...

学会発表実績 | 研究開発活動 | 千寿製薬株式会社

開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model with retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...